Latest Articles
About This Stock
More About This Stock
Read
Read
Read
Seattle Genetics-Takeda Reveal Impressive Adcetris Data
Article By:
Zacks Investment Research
Wednesday, October 1, 2014 12:52 PM EDT
Adcetris is already approved in more than 45 countries for the treatment of relapsed Hodgkin lymphoma and sALCL; now, new positive data as a consolidation therapy post-stem cell transplant.
PSW Trade Review – Thank You Sir, MAY I Have Another! – Part 1
Article By:
Phil Davis
Tuesday, May 27, 2014 7:15 AM EDT
1,900 on the S&P, 16,600 on the Dow! The month isn't quite over yet but we're up about 3% for the year now although, as Dave Fry points out, on record low volumes – which makes the whole thing sort of suspect.
In this article: AZN, LNKD, LUV, NLY, PFE, SDS, EZCH, IRBT, SGEN, AAPL, AKAM, CAKE, CROX, EBAY, PNRA, STX, SLV, SPY, XRT, FB, TWTR
Insider Trading Report: Notable Buys And Sales
Article By:
Asif Suria
Monday, May 19, 2014 5:32 AM EDT
Welcome to edition 204 of Insider Weekends. Insiders went on a shopping spree last week with insider buying jumping to a six month high of $223.51 million compared to $65.72 million in the week prior.